Health Care Sector Witnesses Surge Amid Drug Shortages
The health care sector experienced a notable surge, particularly as drug prices are anticipated to rise in the face of mounting U.S. pharmaceutical shortages. Leading the charge, Novo Nordisk and Eli Lilly have seen impressive gains, each registering increases of over 22% for the first part of the year. This development comes at a critical juncture as the Federal Trade Commission sets its sights on probing the recent scarcities impacting chemotherapies and a range of other essential medications.
Exclusive Access: Unlock Premium, Confidential Insights
Unlock This Exclusive Content—Subscribe Instantly!
Login if you have purchased
